ResMed (RMD) Tops Q2 EPS by 6c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $218.13 -1.32%
Revenue Growth %: +6.9%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
SUNB, CULP, KFY, More
Revenue Growth %: +6.9%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q2 EPS of $1.66, $0.06 better than the analyst estimate of $1.60. Revenue for the quarter came in at $1.03 million versus the consensus estimate of $990.85 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- J.Jill Inc. (JILL) PT Raised to $25 at BTIG
- Texas Instruments (TXN) Reiterated at Neutral by Cantor Fitzgerald on Upside to Earnings Power
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
